Northern Trust’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15M | Buy |
576,471
+10,274
| +2% | +$56.2K | ﹤0.01% | 2742 |
|
|
2025
Q1 | $3.56M | Buy |
566,197
+83,382
| +17% | +$524K | ﹤0.01% | 2604 |
|
|
2024
Q4 | $1.99M | Buy |
482,815
+49,173
| +11% | +$203K | ﹤0.01% | 3026 |
|
|
2024
Q3 | $1.45M | Buy |
433,642
+112,540
| +35% | +$376K | ﹤0.01% | 3179 |
|
|
2024
Q2 | $957K | Sell |
321,102
-6,590
| -2% | -$19.6K | ﹤0.01% | 3266 |
|
|
2024
Q1 | $1.13M | Buy |
327,692
+13,514
| +4% | +$46.6K | ﹤0.01% | 3261 |
|
|
2023
Q4 | $421K | Sell |
314,178
-1,378
| -0.4% | -$1.85K | ﹤0.01% | 3599 |
|
|
2023
Q3 | $688K | Sell |
315,556
-6,001
| -2% | -$13.1K | ﹤0.01% | 3421 |
|
|
2023
Q2 | $769K | Buy |
321,557
+257,374
| +401% | +$615K | ﹤0.01% | 3439 |
|
|
2023
Q1 | $119K | Buy |
64,183
+10,068
| +19% | +$18.6K | ﹤0.01% | 4041 |
|
|
2022
Q4 | $104K | Buy |
54,115
+14,188
| +36% | +$27.4K | ﹤0.01% | 4077 |
|
|
2022
Q3 | $61K | Sell |
39,927
-6,371
| -14% | -$9.73K | ﹤0.01% | 4273 |
|
|
2022
Q2 | $130K | Buy |
46,298
+34,884
| +306% | +$98K | ﹤0.01% | 4072 |
|
|
2022
Q1 | $25K | Hold |
11,414
| – | – | ﹤0.01% | 4649 |
|
|
2021
Q4 | $9K | Hold |
11,414
| – | – | ﹤0.01% | 4744 |
|
|
2021
Q3 | $16K | Hold |
11,414
| – | – | ﹤0.01% | 4618 |
|
|
2021
Q2 | $26K | Hold |
11,414
| – | – | ﹤0.01% | 4528 |
|
|
2021
Q1 | $31K | Hold |
11,414
| – | – | ﹤0.01% | 4418 |
|
|
2020
Q4 | $28K | Hold |
11,414
| – | – | ﹤0.01% | 4296 |
|
|
2020
Q3 | $46K | Sell |
11,414
-4,588
| -29% | -$18.5K | ﹤0.01% | 4115 |
|
|
2020
Q2 | $105K | Sell |
16,002
-478
| -3% | -$3.14K | ﹤0.01% | 3907 |
|
|
2020
Q1 | $54K | Hold |
16,480
| – | – | ﹤0.01% | 3943 |
|
|
2019
Q4 | $62K | Hold |
16,480
| – | – | ﹤0.01% | 4019 |
|
|
2019
Q3 | $74K | Hold |
16,480
| – | – | ﹤0.01% | 3989 |
|
|
2019
Q2 | $124K | Buy |
+16,480
| New | +$124K | ﹤0.01% | 3928 |
|